T0	Interventions 147 149	GH
T1	Interventions 306 318	GH treatment
T2	Interventions 491 509	placebo-controlled
T3	Interventions 525 632	Urinary steroid profile was used to estimate 11betaHSD type 1 and 2 (11betaHSD1 and 11betaHSD2) activities.
T4	Interventions 633 647	Abdominal s.c.
T5	Interventions 648 717	and visceral adipose tissues were measured using computed tomography.
T6	Interventions 718 847	Glucose disposal rate (GDR) obtained during a euglycaemic-hyperinsulinaemic glucose clamp was used to assess insulin sensitivity.